Exane Derivatives Colgate Palmolive CO Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Colgate Palmolive CO stock. As of the latest transaction made, Exane Derivatives holds 9 shares of CL stock, worth $873. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 9
-0.0%
Holding current value
$873
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CL
# of Institutions
1,913Shares Held
664MCall Options Held
11.1MPut Options Held
3.69M-
Vanguard Group Inc Valley Forge, PA79.6MShares$7.73 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY59.5MShares$5.77 Billion0.13% of portfolio
-
State Street Corp Boston, MA46.1MShares$4.48 Billion0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD41.1MShares$3.99 Billion0.45% of portfolio
-
Wellington Management Group LLP Boston, MA27.8MShares$2.7 Billion0.45% of portfolio
About COLGATE PALMOLIVE CO
- Ticker CL
- Exchange NYSE
- Sector Consumer Defensive
- Industry Household & Personal Products
- Shares Outstandng 834,120,000
- Market Cap $80.9B
- Description
- Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, condition...